How Damodaran Cross-Checks a Valuation
high confidence — compiled with source citation from the investment brain.
How Damodaran Cross-Checks a Valuation
How Damodaran Cross-Checks a Valuation
Damodaran's answer to how do you know the number is right is not a single test but a family of triangulations. The recurring move is to invert the model — solve for what the market price implies, then ask whether that implication is plausible. His methods share one premise: a dcf-valuation is a claim about the future, and the price already on the screen is another such claim, so the two can be checked against each other (see intrinsic-value and cost-of-capital).
Reverse DCF: back out the implied growth
The cleanest cross-check is to start from today's price and solve for the growth rate embedded in it. In his firm-valuation walkthrough, after estimating Disney's FCFF, he writes: "Back out the implied growth rate in the current market value." With FCFF of $3,657 million, a current enterprise value of $133,908 million, and a cost of capital of 7.81%, the solved growth rate comes to 4.94% — a number he then judges against whether it is a reasonable long-run assumption for that business.
This is the question of what the market has to believe. It turns valuation from a one-way projection into a hypothesis test: if the implied growth is implausible, the price is stretched; if it is conservative, the stock may be cheap. The same inversion underlies his implied equity risk premium, which he describes as "a forward looking estimate, where you back out from stock prices what investors are building in as an expected return on stocks in the future."
Market-implied cost of capital and ERP
The reverse-engineering logic extends to the discount rate itself. Damodaran warns that the cost of capital is not "a receptacle for your hopes and fears," and explicitly that it "should not be ... a mechanism for reverse engineering a pre-determined value" — i.e., you cannot pick a discount rate to arrive at a target. But going the other direction is legitimate: using market prices to observe the premium investors currently demand. This is a cross-check on the equity-risk-premium and country-risk-premium inputs, not on the company, and it anchors the discount rate in market data rather than analyst optimism.
FCFF and FCFE must reconcile
The third cross-check is internal consistency between the firm and equity views. The FCFF model values the whole firm at the WACC; the FCFE model values equity directly. The two "will be the same if: (a) Consistent assumptions are made about growth in the two approaches (b) Bonds are correctly priced." He notes the firm approach's practical appeal — "cashflows relating to debt do not have to be considered" which matters when "leverage is expected to change significantly over time" — and that it is the right tool for highly levered firms or those with negative FCFE but positive FCFF. A wide gap between the two valuations, once assumptions are aligned, is itself a signal that something is wrong in the inputs (see also terminal-value).
Value vs. price: expect disagreement
Finally, Damodaran reframes the emotional reaction to a valuation that differs from the market. When you value a public company you will almost always get a number different from the traded price; the honest frame is that one of several things is true — you are right and the market wrong, you are wrong and the market right, you are both wrong, or you are both right. The discipline is to treat that disagreement as an invitation to re-audit the inputs rather than to conclude instantly.
Synthesis
The common thread is triangulation across independent estimates of the same value: a bottom-up DCF, the growth rate the market price implies, and the firm-versus-equity split of the same cash flows. When all three point the same way, the valuation has been cross-checked; when they diverge, the divergence itself identifies which assumption is doing the work. (See aswath-damodaran, relative-valuation-multiples, and valuation-across-asset-classes.)
Sources
damodaran/markdown/cfpacket2spr26.mddamodaran/markdown/costofcapital.mddamodaran/markdown/fcff.mddamodaran/markdown/dcfvaltests.md